Paul Agapow

Advisor at Bayezian

United Kingdom

About me

Originally an immunologist, I was drawn into the intersection of the biomedical and computational sciences, bridging the knoiwledge and cultures of the two. Following stints in academia, frontline epidemiology and big pharmaceutical, I’m now advising various companies on the pragmatic use of AI in biotech and drug development.

Schedule

Welcome Address & Chairperson’s Opening Remarks

Begin your conference journey with a warm welcome from our esteemed Chairperson

Paul Agapow

Advisor at Bayezian

Wednesday - May 28, 2025 |
05:00 PM - 05:30 PM |
30 Minutes

Panel Discussion - Empowering drug discovery and development: the AI and Machine Learning revolution?

How pharmaceutical companies are adopting AI to discover new drugs and improve existing ones, and the impact this is having on their R&D strategies
How AI is not just a tool for research but is reshaping business models, leading to collaborations with tech companies, the rise of AI-driven biotech firms, and changes in investment strategies
Strategies to maximize AI & ML's impact in drug discovery and development
Mitigating risks and uncertainties in drug development through AI. Explore how AI is being used to navigate the complexities of both early-stage discovery and late-stage clinical trials

AI and ML in Pharma

Innovation in Drug Discovery

Paul Agapow

Advisor at Bayezian

Julie Klint

Director, Head of Molecular Discovery & Enabling Technologies division at Lundbeck

Calvin Chan

Product Manager - Medical Affairs Analytics at Roche

Ammara Gafoor

Head of Healthcare & Life Sciences , Europe at Thoughtworks

The Digi-Tech Pharma & AI conference is hosted exclusively by Corvus Global Events.

Contact Us

For general conference and registration enquires please contact the below email id or via call

Social Links

Paul Agapow

About me

Schedule

My Session

AI and ML in Pharma

Innovation in Drug Discovery

Don't Miss our regular updates

Get Subscribed Today

Contact Us

Get Involved